Category Archives: Spinal Cord Injury Treatment

Amey Vance, Live Well Published 2:56 p.m. MT Jan. 31, 2020 There are seven vertebrae in the cervical spine area. Continue reading →

Neuralstem (NASDAQ:CUR) and SpringWorks Therapeutics (NASDAQ:SWTX) are both small-cap medical companies, but which is the better investment? Continue reading →

As they do in many areas of medicine, stem cells hold great potential in treating injured spinal cords, but getting them where they need to go is a delicate undertaking. Scientists at the University of California San Diego (UCSD) are now reporting a breakthrough in this area, demonstrating a new injection technique in mice they say can deliver far larger doses of stem cells and avoid some of the dangers of current approaches Continue reading →

Spinal cord injury (SCI) is a common disease with high incidence, disability rate and treatment cost. microRNA (miR)-200a is reported to inhibit Keap1 to activate Nrf2 signaling Continue reading →

Sylvan Lakes health care facility took one step ahead of the rest of central Alberta when they opened their Advanced Ambulatory Care Service on June 4th, 2018. The service provides ambulatory care for the treatment of lesser injuries and illnesses Continue reading →

SI-Bone (NASDAQ:SIBN) and Invivo Therapeutics (NASDAQ:NVIV) are both small-cap medical companies, but which is the better stock? Continue reading →

The "Investigation Report on Chinese Pregabalin Market, 2020-2024" report has been added to ResearchAndMarkets.com's offering. Pregabalin is a new-generation drug for neuralgia treatment. In Jul. Continue reading →

To step up my CCO game, my husband and I recently attended a lecture at Craig Hospital to learn more about spinal cord injury research. Our son, daughters, my parents, uncle and two cousins, who were visiting Colorado, headed out for tacos. While I would have preferred the tacos and their company, I gripped my notebook, pen and can of sparkling water and decided the lecture was the utmost importance to our sons future after he suffered a severe spinal cord injury in late December. Continue reading →

February is Rare Disease Awareness Month, a month-long celebration focused on the suffering and triumphs of patients and their families stricken by rare diseases culminating on February 29th International Rare Disease Day. The rapidly developing cell and gene therapy fields in recent years have led to a rare disease R&D boom of sorts, with an estimated 800 rare disease-focused clinical development projects currently in process Continue reading →

(RTTNews) - Shares of global medical device company Nevro Corp. (NVRO) touched yet another high of $131.27 in early trade on Monday and are currently at $129.96, up 3.09%. Nevro markets the Senza spinal cord stimulation (SCS) system, a neuromodulation solution for the treatment of chronic pain Continue reading →